WITH YOUR Support

Developing medicines to ease the burden of diseases on disadvantaged communities worldwide

Lime green custom graphic

Over 1 billion people suffer from neglected diseases. Most live in poverty and cannot afford to pay for medicines.

They are therefore often overlooked by traditional pharmaceutical models simply because there is no financial incentive to justify the long and costly process of developing a medicine to treat their diseases.

By developing new, innovative medicines we aim to alleviate suffering and accelerate the time to disease elimination.

But we need strong philanthropic support to help us - will you join our commitment to make medicines accessible to everyone? Will you join us in our commitment to make medicines accessible to everyone?

Lime green graphic with four dots with arrow facing downElephantiasis

MDGH is currently developing two medicines: moxidectin and dovramilast.

Together, these medicines are targeting seven different diseases that collectively impact more than 1 billion people. With your support we can continue to progress the development of these medicines.

It costs us (USD):

$1.5M - $10M

to run one clinical trial

~$150,000

to manufacture one batch of medicine

~$5,000

to support one participant in a clinical trial

~$20,000

to provide clinical trial supplies to one site

We have the expertise and tools required to develop and deliver medicines for the treatment of numerous neglected diseases, and there is potential for millions of people to benefit from our work. But we need your support.

There is perhaps no greater gift than providing a medicine to treat or prevent a disease for someone who otherwise would not have access.

Will you join us in our commitment to make medicines accessible to everyone? Speak with our team about funding opportunities today.

Did you know that Nigeria alone could gain approximately US$19 billion in increased productivity by meeting its 2030 elimination targets for five neglected diseases?